Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells
- 5 March 2024
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 26 (7) , 719-728
Abstract
No abstract availableKeywords
Funding Information
- Royal Brisbane and Women's Hospital Foundation
- National Health and Medical Research Council (GNT 1163111)
- Queensland University of Technology
- Miltenyi Biotec
- Cancer Council Queensland
- Metro North Hospital and Health Service
This publication has 47 references indexed in Scilit:
- Helios is a marker, not a driver, of human Treg stabilityEuropean Journal of Immunology, 2021
- Building a CAR-Treg: Going from the basic to the luxury modelCellular Immunology, 2020
- Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35Transplantation and Cellular Therapy, 2020
- A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyCytotherapy, 2016
- Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host diseaseCytotherapy, 2015
- International Society for the Advancement of Cytometry cell sorter biosafety standardsCytometry Part A, 2014
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cellsClinical Immunology, 2009
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009
- DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cellsEuropean Journal of Immunology, 2007
- Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell TransplantationTransplantation and Cellular Therapy, 2007